Drug pricing a barrier to HIV elimination

Increasing the availability of generic life-saving treatments for HIV/AIDS could save 355,000 lives and prevent 594,000 new infections each year for a fraction of the cost of current patented HIV drug sales, new modelling presented at AIDS 2020, shows.